Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The quote from Alliacense is all the more reason clarification is needed from...

The quote from Alliacense is all the more reason clarification is needed from...

posted on Mar 26, 2009 12:29PM

PTSC. Why are they comforted? Was the rejection from the USPTO expected or did they get blindsided? It sounds as if they dodged a bullet. And another thing, this kind of statement comes damn close to sounding like a "Material Event" to me. I think Patriot's walking a thin line on that particular topic concerning the '336 Final Rejection. The only thing that could hold it at bay, IMO, would be current communication between parties to rectify the situation.

“We are pleased with Roche’s decision to purchase an MMP Portfolio license”, said Andre-Pascal Chauvin, VP of Licensing in Alliacense’s European office. “Recently comforted by the positive decision of the German Federal Patent Court in Munich our MMP Portfolio is more than ever adding real value to market success, and enabling real growth.”

Share
New Message
Please login to post a reply